AG

Alastair Goldfisher

Proof fund raises $18.6 mln toward target

Reston, Virginia-based Proof has raised more than $18.6 million toward a targeted $100 million fund, according to a regulatory filing. The filing reports the commitments to date have come from 44 investors. The fund, co-founded by John Backus, John Burke and Thanasis Delistathis, teams up with early-stage firms to support their pro-rata investments in subsequent rounds of their portfolio companies. Investments include Beyond Meat, Casper and Signifyd, among others.

1 min read · 08 May 2018

Mesosphere raises $125 mln

San Francisco-based Mesosphere, provider of a cloud computing platform, announced it has raised $125 million in Series D funding. T. Rowe Price Associates Inc and Koch Disruptive Technologies co-led the round with participation from ZWC Ventures, Qatar Investment Authority and Disruptive Technology Advisers. Existing investors Andreessen Horowitz, Two Sigma Ventures, Khosla Ventures and Hewlett Packard Enterprise also participated in the round. The company, founded in 2013, as now raised about $250 million in total funding.

4 min read · 07 May 2018

Healthcare-focused Foresite Capital raises $668 mln for data-driven approach

2 min read · 03 May 2018

BounceX raises $37 mln round led by Battery Ventures

New York-based BounceX, which provides behavioral software to direct marketing campaigns, announced it has raised $37 million in a Series B round of funding. Battery Ventures led the round, which included participation from Contour Venture Partners, Primary Venture Partners and Cross Creek Advisors, among others. Founded in 2012, the company has now raised $69 million in total funding. As part of the latest round, Neeraj Agrawal, a general partner at Battery Ventures, has joined the board.

3 min read · 03 May 2018

Marketing outlays a key part of growth-stage firms: Edison Partners survey

2 min read · 01 May 2018

Salesforce leads $24 mln funding of IFTTT

San Francisco-based IFTTT, which provides a utility for users to connect their apps, services and smart devices, announced it has raised $24 million in new funding led by Salesforce Ventures. IBM, Chamberlain Group and Fenox Venture Capital also participated in the round. IFTTT, which stand for "If This, Then That," was founded in 2010 and has now raised $63 million in total funding. Other investors include Andreessen Horowitz, Lerer Hippeau Ventures, New Enterprise Associates, Norwest Venture Partners and SV Angel.

4 min read · 26 April 2018

Ready Robotics announces $15 mln, move to Ohio

Ready Robotics, provider of robotics as a service or RaaS, announced it has raised $15 million in funding and is relocating to Columbus, Ohio, from Baltimore. Columbus based Drive Capital led the round, which included Eniac Ventures and RRE Ventures. The company, founded in 2016, has now raised nearly $19 million in total funding

1 min read · 25 April 2018

Ana Quintana named managing partner at Black Diamond Ventures

Glendale, California-based Black Diamond Ventures, which focuses on early to mid-stage companies in biotech, medical devices, semiconductor design, data science and mobile applications, announced it has promoted Ana Quintana to managing partner. Quintana joined the firm as a director in 2000 and has participated as an operating partner in several startups. She was most recently a principal at the firm, according to her LinkedIn profile. She is also co-founder of She Ventures in Tech, which provides entrepreneurial support for women with existing tech startups.

3 min read · 25 April 2018

GitPrime raises $10.5 mln

Durango, Colorado-based GitPrime, a provider of software engineering analytics, announced it has raised $10.5 million in Series A funding led by OpenView. Existing investor Data Collective also participated in the round. The company, which was a member of the Y Combinator 2016 Winter batch, has now raised $13 million in total funding. As part of the latest round, Mackey Craven, a partner at OpenView, has joined the board.

1 min read · 25 April 2018

Venrock healthcare survey shows pessimism on drug pricing

Skepticism remains high that the drug pricing debate will lead to action despite the FDA vowing to combat high drug prices. That was one of the findings in a survey of 300 healthcare experts conducted by the venture firm Venrock. A majority of those polled said that they believe there will still be more talk than action on prescription drug prices, with 19 percent believing that nothing will happen with prescription drug prices.

1 min read · 25 April 2018

Showing 771 to 780 of 2,688 results
1…7779…269